Oxidative and nitrative DNA damage: Key events in opisthorchiasis-induced carcinogenesis

Parasitology International

Volumn 61, Issue 1, 2012, Pages 130-135

  Yongvanit, Puangrat ^a   Pinlaor, Somchai ^a   Bartsch, Helmut ^b,c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NONE   (Germany)

Author keywords

Chemopreventive agents; Lipid peroxidation derived DNA adducts; Opisthorchis viverrini; Oxidative and nitrative DNA damage; Periductal fibrosis; Risk markers

Indexed keywords

CURCUMIN; PRAZIQUANTEL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; DNA DAMAGE; DRUG ACTIVITY; HEPATITIS; HUMAN; IMMUNITY; NITRATIVE STRESS; NONHUMAN; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALIA; FASCIOLA HEPATICA; OPISTHORCHIS VIVERRINI; TREMATODA;

EID: 82655162242     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2011.06.011     Document Type: Article

References (77)

1. Jongsuksuntigul P., Imsomboon T. Opisthorchiasis control in Thailand. Acta Trop 2003, 88:229-232.
2. Saowakontha S., Pongpaew P., Vudhivai N., Tungtrongchitr R., Sanchaisuriya P., Mahaweerawat U., et al. Promotion of the health of rural women towards safe motherhood-an intervention project in northeast Thailand. Southeast Asian J Trop Med Public Health 2000, 31(Suppl. 2):5-21.
3. Sripa B., Kaewkes S., Sithithaworn P., Mairiang E., Laha T., Smout M., et al. Liver fluke induces cholangiocarcinoma. PLoS Med 2007, 4:e201.
4. Sriamporn S., Pisani P., Pipitgool V., Suwanrungruang K., Kamsa-ard S., Parkin D.M. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health 2004, 9:588-594.
5. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
6. Hussain S.P., Hofseth L.J., Harris C.C. Radical causes of cancer. Nat Rev Cancer 2003, 3:276-285.
7. Kawanishi S., Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 2006, 8:1047-1058.
8. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
9. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994, 305:253-264.
10. Karin M., Lawrence T., Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-835.
11. Hussain S.P., Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007, 121:2373-2380.
12. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5:749-759.
13. Ohshima H., Sawa T., Akaike T. 8-nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid Redox Signal 2006, 8:1033-1045.
14. Nair U., Bartsch H., Nair J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 2007, 43:1109-1120.
15. Singer B., Hang B. Mammalian enzymatic repair of etheno and para-benzoquinone exocyclic adducts derived from the carcinogens vinyl chloride and benzene. IARC Sci Publ 1999, 233-247.
16. el Ghissassi F., Barbin A., Nair J., Bartsch H. Formation of 1,N6-ethenoadenine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem Res Toxicol 1995, 8:278-283.
17. Meerang M., Nair J., Sirankapracha P., Thephinlap C., Srichairatanakool S., Fucharoen S., et al. Increased urinary 1, N6-ethenodeoxyadenosine and 3, N4-ethenodeoxycytidine excretion in thalassemia patients: markers for lipid peroxidation-induced DNA damage. Free Radic Biol Med 2008, 44:1863-1868.
18. Bartsch H., Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg 2006, 391:499-510.
19. Nair J., Gansauge F., Beger H., Dolara P., Winde G., Bartsch H. Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxid Redox Signal 2006, 8:1003-1010.
20. Wykoff D.E., Chittayasothorn K., Winn M.M. Clinical manifestations of Opisthorchis viverrini infections in Thailand. Am J Trop Med Hyg 1966, 15:914-918.
21. Bhamarapravati N., Thammavit W., Vajrasthira S. Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini. Am J Trop Med Hyg 1978, 27:787-794.
22. Chotigeat W., Ruenwongsa P. Types of collagen in Opisthorchis viverrini infected hamster liver. Mol Biochem Parasitol 1986, 18:377-387.
23. Hutadilok N., Ruenwongsa P. Liver collagen turnover in hamsters during infection by the human liver fluke, Opisthorchis viverrini. Mol Biochem Parasitol 1983, 8:71-77.
24. Sripa B., Kaewkes S. Relationship between parasite-specific antibody responses and intensity of Opisthorchis viverrini infection in hamsters. Parasite Immunol 2000, 22:139-145.
25. Akai P.S., Pungpak S., Chaicumpa W., Kitikoon V., Ruangkunaporn Y., Bunnag D., et al. Serum antibody responses in opisthorchiasis. Int J Parasitol 1995, 25:971-973.
26. Itoh M., Pairojkul C., Thamawit W., Sithithaworn P., Tiwawech D., Uttaravicien T., et al. Association of antibodies to Opisthorchis viverrini with hepatobiliary disease in northeastern Thailand. Am J Trop Med Hyg 1994, 51:424-429.
27. Sirisinha S., Tuti S., Vichasri S., Tawatsin A. Humoral immune responses in hamsters infected with Opisthorchis viverrini. Southeast Asian J Trop Med Public Health 1983, 14:243-251.
28. Elkins D.B., Mairiang E., Sithithaworn P., Mairiang P., Chaiyakum J., Chamadol N., et al. Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans. Am J Trop Med Hyg 1996, 55:295-301.
29. Pinlaor S., Sripa B., Sithithaworn P., Yongvanit P. Hepatobiliary changes, antibody response, and alteration of liver enzymes in hamsters re-infected with Opisthorchis viverrini. Exp Parasitol 2004, 108:32-39.
30. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 2008, 214:199-210.
31. Prakobwong S., Pinlaor S., Yongvanit P., Sithithaworn P., Pairojkul C., Hiraku Y. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Int J Parasitol 2009, 39:825-835.
32. Thannickal V.J., Toews G.B., White E.S., Lynch J.P., Martinez F.J. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004, 55:395-417.
33. Mairiang E., Elkins D.B., Mairiang P., Chaiyakum J., Chamadol N., Loapaiboon V., et al. Relationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonography. J Gastroenterol Hepatol 1992, 7:17-21.
34. Sripa B., Mairiang E., Thinkhamrop B., Laha T., Kaewkes S., Sithithaworn P., et al. Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatology 2009, 50:1273-1281.
35. Khoontawad J., Wongkham C., Hiraku Y., Yongvanit P., Prakobwong S., Boonmars T., et al. Proteomic identification of peroxiredoxin 6 for host defence against Opisthorchis viverrini infection. Parasite Immunol 2010, 32:314-323.
36. Blechacz B., Gores G.J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008, 48:308-321.
37. Nakeeb A., Pitt H.A., Sohn T.A., Coleman J., Abrams R.A., Piantadosi S., et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996, 224:463-473. [discussion 473-465].
38. Khan S.A., Miras A., Pelling M., Taylor-Robinson S.D. Cholangiocarcinoma and its management. Gut 2007, 56:1755-1756.
39. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B. El Ghissassi F et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009, 10:321-322.
40. Thammapalerd N., Tharavanij S., Nacapunchai D., Bunnag D., Radomyos P., Prasertsiriroj V. Detection of antibodies against Opisthorchis viverrini in patients before and after treatment with praziquantel. Southeast Asian J Trop Med Public Health 1988, 19:101-108.
41. Harinasuta T., Riganti M., Bunnag D. Opisthorchis viverrini infection: pathogenesis and clinical features. Arzneimittelforschung 1984, 34:1167-1169.
42. Kim Y.I. Liver carcinoma and liver fluke infection. Arzneimittelforschung 1984, 34:1121-1126.
43. Viranuvatti V., Stitnimankarn T. Liver fluke infection and infestation in Southeast Asia. Prog Liver Dis 1972, 4:537-547.
44. Flavell D.J. Liver-fluke infection as an aetiological factor in bile-duct carcinoma of man. Trans R Soc Trop Med Hyg 1981, 75:814-824.
45. Flavell D.J., Flavell S.U. Opisthorchis viverrini: pathogenesis of infection in immunodeprived hamsters. Parasite Immunol 1986, 8:455-466.
46. Haswell-Elkins M.R., Sithithaworn P., Mairiang E., Elkins D.B., Wongratanacheewin S., Kaewkes S., et al. Immune responsiveness and parasite-specific antibody levels in human hepatobiliary disease associated with Opisthorchis viverrini infection. Clin Exp Immunol 1991, 84:213-218.
47. Honjo S., Srivatanakul P., Sriplung H., Kikukawa H., Hanai S., Uchida K., et al. Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer 2005, 117:854-860.
48. Ohshima H., Tatemichi M., Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003, 417:3-11.
49. Inoue S., Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 1995, 371:86-88.
50. Haswell-Elkins M.R., Mairiang E., Mairiang P., Chaiyakum J., Chamadol N., Loapaiboon V., et al. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 1994, 59:505-509.
51. Srivatanakul P., Ohshima H., Khlat M., Parkin M., Sukaryodhin S., Brouet I., et al. Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer 1991, 48:821-825.
52. Satarug S., Haswell-Elkins M.R., Tsuda M., Mairiang P., Sithithaworn P., Mairiang E., et al. Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection. Carcinogenesis 1996, 17:1075-1081.
53. Satarug S., Haswell-Elkins M.R., Sithithaworn P., Bartsch H., Ohshima H., Tsuda M., et al. Relationships between the synthesis of N-nitrosodimethylamine and immune responses to chronic infection with the carcinogenic parasite, Opisthorchis viverrini, in men. Carcinogenesis 1998, 19:485-491.
54. Kirby G.M., Pelkonen P., Vatanasapt V., Camus A.M., Wild C.P., Lang M.A. Association of liver fluke (Opisthorchis viverrini) infestation with increased expression of cytochrome P450 and carcinogen metabolism in male hamster liver. Mol Carcinog 1994, 11:81-89.
55. Satarug S., Lang M.A., Yongvanit P., Sithithaworn P., Mairiang E., Mairiang P., et al. Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. Cancer Epidemiol Biomarkers Prev 1996, 5:795-800.
56. Pinlaor S., Ma N., Hiraku Y., Yongvanit P., Semba R., Oikawa S., et al. Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis 2004, 25:1535-1542.
57. Pinlaor S., Yongvanit P., Hiraku Y., Ma N., Semba R., Oikawa S., et al. 8-nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini. Biochem Biophys Res Commun 2003, 309:567-571.
58. Kaneko T., Tahara S. Formation of 8-oxo-2'-deoxyguanosine in the DNA of human diploid fibroblasts by treatment with linoleic acid hydroperoxide and ferric ion. Lipids 2000, 35:961-965.
59. Dechakhamphu S., Pinlaor S., Sitthithaworn P., Bartsch H., Yongvanit P. Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters. Mutat Res 2010.
60. Lau A.Y., Wyatt M.D., Glassner B.J., Samson L.D., Ellenberger T. Molecular basis for discriminating between normal and damaged bases by the human alkyladenine glycosylase, AAG. Proc Natl Acad Sci USA 2000, 97:13573-13578.
61. Dechakhamphu S., Pinlaor S., Sitthithaworn P., Nair J., Bartsch H., Yongvanit P. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel. Cancer Epidemiol Biomarkers Prev 2010, 19:310-318.
62. Dechakhamphu S., Yongvanit P., Nair J., Pinlaor S., Sitthithaworn P., Bartsch H. High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage. Cancer Epidemiol Biomarkers Prev 2008, 17:1658-1664.
63. Thanan R., Murata M., Pinlaor S., Sithithaworn P., Khuntikeo N., Tangkanakul W., et al. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis. Cancer Epidemiol Biomarkers Prev 2008, 17:518-524.
64. Pinlaor S., Sripa B., Ma N., Hiraku Y., Yongvanit P., Wongkham S., et al. Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion. World J Gastroenterol 2005, 11:4644-4649.
65. Pinlaor S., Tada-Oikawa S., Hiraku Y., Pinlaor P., Ma N., Sithithaworn P., et al. Opisthorchis viverrini antigen induces the expression of Toll-like receptor 2 in macrophage RAW cell line. Int J Parasitol 2005, 35:591-596.
66. Pinlaor S., Hiraku Y., Ma N., Yongvanit P., Semba R., Oikawa S., et al. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide 2004, 11:175-183.
67. Loilome W., Yongvanit P., Wongkham C., Tepsiri N., Sripa B., Sithithaworn P., et al. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. Mol Carcinog 2006, 45:279-287.
68. Loilome W., Juntana S., Namwat N., Bhudhisawasdi V., Puapairoj A., Sripa B., et al. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma. Int J Cancer 2011, 129:34-44.
69. Techasen A., Loilome W., Namwat N., Takahashi E., Sugihara E., Puapairoj A., et al. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Cancer Sci 2010, 101:658-665.
70. Prakobwong S., Yongvanit P., Hiraku Y., Pairojkul C., Sithithaworn P., Pinlaor P., et al. Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model. Int J Cancer 2010, 127:2576-2587.
71. Pinlaor S., Hiraku Y., Yongvanit P., Tada-Oikawa S., Ma N., Pinlaor P., et al. iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel. Int J Cancer 2006, 119:1067-1072.
72. Pinlaor S., Prakobwong S., Hiraku Y., Kaewsamut B., Dechakhamphu S., Boonmars T., et al. Oxidative and nitrative stress in Opisthorchis viverrini-infected hamsters: an indirect effect after praziquantel treatment. Am J Trop Med Hyg 2008, 78:564-573.
73. Pinlaor S., Yongvanit P., Prakobwong S., Kaewsamut B., Khoontawad J., Pinlaor P., et al. Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini. Mol Nutr Food Res 2009, 53:1316-1328.
74. Pinlaor S., Prakobwong S., Hiraku Y., Pinlaor P., Laothong U., Yongvanit P. Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment. Eur J Pharmacol 2010, 638:134-141.
75. Prakobwong S., Khoontawad J., Yongvanit P., Pairojkul C., Hiraku Y., Sithithaworn P., et al. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. Int J Cancer 2011, 129:88-100.
76. Charoensuk L., Pinlaor P., Prakobwong S., Hiraku Y., Laothong U., Ruangjirachuporn W., et al. Curcumin induces a nuclear factor-erythroid 2-related factor 2-driven response against oxidative and nitrative stress after praziquantel treatment in liver fluke-infected hamsters. Int J Parasitol 2011, 41:615-626.
77. Laothong U., Pinlaor P., Hiraku Y., Boonsiri P., Prakobwong S., Khoontawad J., et al. Protective effect of melatonin against Opisthorchis viverrini-induced oxidative and nitrosative DNA damage and liver injury in hamsters. J Pineal Res 2010, 49:271-282.